Screening: Why, when, and how

Kidney International

Volumn 76, Issue 7, 2009, Pages 694-699

  Grootendorst, Diana C ^a   Jager, Kitty J ^b   Zoccali, Carmine ^c   Dekker, Friedo W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

Clinical epidemiology; Epidemiology and outcomes

Indexed keywords

CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIALYSIS; DISEASE CLASSIFICATION; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HIGH RISK POPULATION; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCREENING; TREATMENT INDICATION; WORLD HEALTH ORGANIZATION;

EID: 70349204017     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.232     Document Type: Article

References (33)

1. Wilson J, Jungner G. Principles and practice of screening for disease. WHO Public Health Papers 1968; 34: 1-163.
2. Andermann A, Blancquaert I, Beauchamp S et al. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ 2008; 86: 317-319.
3. Glassock RJ, Winearls C. The global burden of chronic kidney disease: how valid are the estimates? Nephron Clin Pract 2008; 110: c39-c46.
4. Meguid El NA, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005; 365: 331-340.
5. Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis 2007; 50: 169-180.
6. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
7. Glassock RJ, Winearls C. Screening for CKD with eGFR: doubts and dangers. Clin J Am Soc Nephrol 2008; 3: 1563-1568.
8. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 2001; 59: 260-269.
9. Maki DD, Ma JZ, Louis TA et al. Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med 1995; 155: 1073-1080.
10. Pedrini MT, Levey AS, Lau J et al. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med 1996; 124: 627-632.
11. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 1993; 341: 1306-1309.
12. Gouva C, Nikolopoulos P, Ioannidis JP et al. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 2004; 66: 753-760.
13. Clase CM. Glomerular filtration rate: screening cannot be recommended on the basis of current knowledge. BMJ 2006; 333: 1030-1031.
14. Konta T, Hao Z, Takasaki S et al. Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clin Exp Nephrol 2007; 11: 51-55.
15. Gansevoort RT, Verhave JC, Hillege HL et al. The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int Suppl 2005; 94: S28-S35.
16. de Jong PE, Halbesma N, Gansevoort RT. Screening for early chronic kidney disease-what method fits best? Nephrol Dial Transplant 2006; 21: 2358-2361.
17. Delanaye P, Cohen EP. Formula-based estimates of the GFR: equations variable and uncertain. Nephron Clin Pract 2008; 110: c48-c53.
18. Stevens LA, Coresh J, Greene T et al. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473-2483.
19. Foster MC, Hwang SJ, Larson MG et al. Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes. Arch Intern Med 2007; 167: 1386-1392.
20. Halbesma N, Kuiken DS, Brantsma AH et al. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol 2006; 17: 2582-2590.
21. John R, Webb M, Young A et al. Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis 2004; 43: 825-835.
22. van Stralen KJ, Stel VS, Reitsma JB et al. Diagnostic methods I: sensitivity, specificity, and other measures of accuracy. Kidney Int 2009 (in press).
23. Atthobari J, Asselbergs FW, Boersma C et al. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: a pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT). Clin Ther 2006; 28: 432-444.
24. Boulware LE, Jaar BG, Tarver-Carr ME et al. Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA 2003; 290: 3101-3114.
25. Bello AK, Peters J, Wight J et al. A population-based screening for microalbuminuria among relatives of CKD patients: the Kidney Evaluation and Awareness Program in Sheffield (KEAPS). Am J Kidney Dis 2008; 52: 434-443.
26. Brown WW, Peters RM, Ohmit SE et al. Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2003; 42: 22-35.
27. Hallan SI, Dahl K, Oien CM et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 2006; 333: 1047.
28. Bang H, Vupputuri S, Shoham DA et al. SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med 2007; 167: 374-381.
29. Kshirsagar AV, Bang H, Bomback AS et al. A simple algorithm to predict incident kidney disease. Arch Intern Med 2008; 168: 2466-2473.
30. Tripepi G, Jager KJ, Dekker FW et al. Bias in clinical research. Kidney Int 2008; 73: 148-153.
31. Churchill DN. An evidence-based approach to earlier initiation of dialysis. Am J Kidney Dis 1997; 30: 899-906.
32. Korevaar JC, Jansen MA, Dekker FW et al. When to initiate dialysis: effect of proposed US guidelines on survival. Lancet 2001; 358: 1046-1050.
33. Traynor JP, Simpson K, Geddes CC et al. Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure. J Am Soc Nephrol 2002; 13: 2125-2132.